Drug recall D-0575-2021
Product
BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE TABLETS 2.5 mg/6.25 mg, 100-count bottles, Rx Only, Distributed by: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054 NDC 0093-3241-01 RX; TABLETS
Reason for recall
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Lots and codes
1417295A
Recall details
- Recalling firm
- Cardinal Health Inc., Dublin, OH
- Quantity
- 235 bottles
- Distribution
- FL, GA, SC
- Type
- Voluntary: Firm initiated
- Recall initiated
- March 15, 2021
- Terminated
- June 17, 2024
Related products
- Bisoprolol fumarate and hydrochlorothiazide – drug information
- NDC 0093-3241 Bisoprolol fumarate and hydrochlorothiazide · Bisoprolol Fumarate 2.5 mg/1; Hydrochlorothiazide 6.25 mg/1 · Teva Pharmaceuticals USA, Inc.
- NDC 0093-3242 Bisoprolol fumarate and hydrochlorothiazide · Bisoprolol Fumarate 5 mg/1; Hydrochlorothiazide 6.25 mg/1 · Teva Pharmaceuticals USA, Inc.
- NDC 0093-3243 Bisoprolol fumarate and hydrochlorothiazide · Bisoprolol Fumarate 10 mg/1; Hydrochlorothiazide 6.25 mg/1 · Teva Pharmaceuticals USA, Inc.